 Connection
Peter Moore to Fibrinolytic Agents
This is a "connection" page, showing publications Peter Moore has written about Fibrinolytic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.052 |
|
|
|
-
Moore PK, Hershberger DM, Barrett CD. Intrapleural Fibrinolytic Therapy: Past, Present, and Future. Chest. 2026 Feb; 169(2):360-370.
Score: 0.741
-
Maginot ER, Gawargi FI, Moore EE, White CM, Volk GE, Moody TB, Sextro KS, Hiser D, Tierney JF, Sheppard OO, Evans CH, Cantrell E, Kamien AJ, Lamb GD, Matos M, Veatch J, Cloonan MR, Chandler JG, Moore HB, Moore PK, Sauaia A, Bernhardt IM, Yaffe MB, Bauman ZM, Henry R, Barrett CD. Plasminogen supplementation improves lysis of inflammatory retained traumatic hemothorax. J Trauma Acute Care Surg. 2026 01 01; 100(1):20-27.
Score: 0.182
-
Moore HB, Barrett CD, Moore EE, McIntyre RC, Moore PK, Talmor DS, Moore FA, Yaffe MB. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? J Trauma Acute Care Surg. 2020 06; 88(6):713-714.
Score: 0.129
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|